Research ArticleEbola virus

A screen of approved drugs and molecular probes identifies therapeutics with anti–Ebola virus activity

See allHide authors and affiliations

Science Translational Medicine  03 Jun 2015:
Vol. 7, Issue 290, pp. 290ra89
DOI: 10.1126/scitranslmed.aaa5597

Drug repurposing for Ebola virus

The recent Ebola virus outbreak has highlighted the lack of therapies for filovirus infection. FDA-approved drugs serve as a source of medications with a proven safety record. Johansen et al. have now screened about 2600 FDA-approved drugs and molecular probes and found 80 that have some efficacy against Zaire ebolavirus in vitro. These drugs were mechanistically diverse, and several drugs, including a calcium channel blocker and an antidepressant, could protect against infection in a mouse model. Although new therapy development is ongoing, these repurposed drugs can rapidly move to human testing and may serve on the frontline against Ebolavirus infection.

View Full Text

Stay Connected to
   Science Translational Medicine